N-(7-Methyl-1,8-naphthyridin-2-yl)acetamide–acetic acid (1/1)

por Gou, Gao-Zhang, Ma, Rui, Zhou, Qing-Di, Chi, Shao-Ming
Publicado 2013

N-(7-Dibromo­methyl-5-methyl-1,8-naphthyridin-2-yl)acetamide–pyrrolidine-2,5-dione (1/1)

por Gou, Gao-Zhang, Kou, Jun-Feng, Zhou, Qing-Di, Chi, Shao-Ming
Publicado 2013

Crystal structure of 4-acetamido­benzoic acid monohydrate

por Cai, Wen-Juan, Chi, Shao-Ming, Kou, Jun-Feng, Liu, Feng-Yi
Publicado 2014

Crystal structure of 9-(di­bromo­meth­yl)-1,1-di­fluoro-3,7-dimethyl-1H-[1,3,5,2]oxadi­aza­borinino[3,4-a][1,8]naphthyridin-11-ium-1-uide

por Wang, Bang Zhong, Zhou, Jun Ping, Zhou, Yong, Luo, Jian Song, Chi, Shao Ming
Publicado 2016

Crystal structure of N-(7-di­bromo­methyl-5-methyl-1,8-naphthyridin-2-yl)benzamide–pyrrolidine-2,5-dione (1/1)

por Wang, Bang Zhong, Zhou, Jun Ping, Zhou, Yong, Luo, Jian Song, Yang, Jun Jie, Chi, Shao M.ing
Publicado 2017

Solubility and biological activity enhancement of docetaxel via formation of inclusion complexes with three alkylenediamine-modified β-cyclodextrins

por Chen, Xiang-Yu, Yang, Hui-Wen, Chi, Shao-Ming, Yue, Lu-Lu, Ruan, Qiong, Lei, Ze, Zhu, Hong-You, Zhao, Yan
Publicado 2021